All Supplements
    Supplement

    Alpha-Lipoic AcidNew

    Supplement
    Antioxidants
    7/10 Evidence

    Alpha-lipoic acid (ALA) is a mitochondria-made, universal antioxidant active in both water- and fat-soluble environments. It regenerates vitamins C and E and glutathione, activates AMPK, and supports glucose metabolism and nerve health. A 2025 dose-response meta-analysis of 63 randomized trials found modest improvements in fasting glucose, HbA1c, insulin sensitivity, body composition and inflammatory markers.

    Mechanism of Action

    Cofactor for mitochondrial dehydrogenase complexes. Regenerates vitamins C and E and glutathione, and chelates heavy metals. Activates AMPK and improves insulin-stimulated glucose uptake, lowering oxidative stress.

    Latest Research

    Reviewed Sep 15, 2026

    A 2025 systematic review and dose-response meta-analysis of 63 randomized controlled trials (Nutrition, Metabolism & Cardiovascular Diseases) found that alpha-lipoic acid (ALA) supplementation modestly improved several cardiometabolic markers versus control: fasting blood glucose fell by about 5.3 mg/dL, HbA1c by 0.40 percentage points and HOMA-IR by 0.74, alongside small reductions in body weight, BMI, waist circumference, total cholesterol and triglycerides; LDL, HDL and blood pressure were unchanged. A separate 2021 dose-response meta-analysis (20 RCTs) reported lower CRP (−0.69 mg/L), IL-6 (−1.83 pg/mL) and TNF-α, and a 2024 meta-analysis in chronic kidney disease found reduced high-sensitivity CRP (−2.91 mg/L). These are pooled, population-level effects that do not guarantee individual results; ALA is a dietary supplement, not a drug, and is not intended to diagnose, treat, cure or prevent any disease. Because ALA can lower blood glucose, discuss use with your physician if you take insulin or other glucose-lowering medication, and separate dosing from thyroid medication by about four hours.

    Alpha-lipoic acid vs control · 63 RCTs · dose-response meta-analysis

    ALA & cardiometabolic blood markers

    Source: Mohammadi S, et al. Effects of alpha-lipoic acid supplementation on cardiometabolic risk factors: a systematic review and dose-response meta-analysis of 63 randomized controlled trials. Nutrition, Metabolism & Cardiovascular Diseases, 2025. Bars show the weighted mean difference vs control; whiskers are the 95% CI. ALA also lowered HbA1c (−0.40%), HOMA-IR (−0.74), fasting insulin, body weight, BMI and waist circumference; LDL, HDL and blood pressure were unchanged.

    Dosing Protocol

    Recommended

    600mg R-ALAmg

    Standard starting dose based on research

    Therapeutic Range

    300

    Minimum

    to

    1200

    Maximum

    mg

    On empty stomach, split doses

    Dosages are general guidelines. Individual requirements vary based on body weight, health status, and specific goals. Start with lower doses and adjust based on response.

    Benefits

    Primary Benefits

    • Blood sugar regulation
    • Neuroprotection
    • Antioxidant recycling
    • Heavy metal chelation

    Secondary Benefits

    Liver support
    Skin health
    Weight management

    Safety Information

    Contraindications

    Do not use if any of the following apply:

    • Insulin or sulfonylureas (monitor glucose)
    • Thyroid medication (separate by 4h)

    Potential Side Effects

    Some users may experience:

    GI upset
    Skin rash (rare)
    Hypoglycemia in diabetics

    This is not a complete list of interactions or side effects. Individual responses vary. Always start with the lowest effective dose and monitor your response. Report any adverse effects to your healthcare provider.

    Quality Markers

    Look for these specific quality indicators when sourcing this compound:

    • R-alpha lipoic acid form
    • Stabilized
    • GMP certified

    Trusted Certifications

    NSF Certified
    USP Verified
    GMP Certified
    ConsumerLab Approved

    Note: Supplement quality varies dramatically between brands. Cheap supplements often contain fillers, incorrect doses, or contaminants. Investing in quality products from reputable manufacturers is essential for safety and efficacy.

    Evidence Profile

    Evidence Score

    7/10

    Moderate Evidence

    Some clinical trials with positive results, emerging research

    Classification:
    Moderate Evidence

    Evidence Scale

    8-10

    Strong

    5-7

    Moderate

    1-4

    Emerging

    PHS
    671
    / 1000
    T3
    Longevity Operator

    Sample member

    Longevity Operator

    The Peak Human Score · PHS v1

    One number for your longevity journey.

    FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.

    • Metabolic
    • Hormonal
    • Cardiovascular
    • Brain / Cognitive
    • Sleep
    • Musculoskeletal
    • Gut
    • Immunity / Inflammation